Hossam A. Abdelsamed
Caitlin C. Zebley
Ben Youngblood- 1Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, United States
- 2Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN, United States
Memory CD8 T cells have a unique ability to provide lifelong immunity against pathogens containing their cognate epitope. Because of their ability to provide lifelong protection, the generation of memory T cells is now a major focus for current vaccination or adoptive cell therapy approaches to treat chronic viral infections and cancer. It is now clear that maintenance of memory CD8 T cells occurs through a process of antigen-independent homeostatic proliferation, which is regulated in part by the gamma chain cytokines IL-7 and IL-15. Here, we will describe the role of these cytokines in the survival and self-renewal of memory CD8 T cells. Further, we will describe the role of epigenetics in the maintenance of acquired functions among memory CD8 T cells during homeostatic proliferation.
Memory T-Cell Homeostasis
Much of the inspiration for investigating the mechanisms involved in T cell development and maintenance, which ultimately identified common gamma chain cytokines, was borne out of the pathophysiology observed in patients with severe combined immunodeficiency. The ensuing discovery of mutations in the common gamma chain (γc) receptor and its downstream signaling molecules further served as a major impetus for investigating the mechanisms that govern T cell homeostasis (1–5). Building upon these findings, a series of in vitro and in vivo studies confirmed the importance of γc cytokine signaling in T cell homeostasis (6–16). Notably, Berard et al. showed that low concentrations of IL-15 could promote the survival of naïve and memory murine CD8 T cells in the presence of MHC, whereas higher concentrations of IL-15 were sufficient to stimulate antigen-independent proliferation of memory CD8 T cells (15). Similarly, Cho et al. showed that exposure to high concentrations of IL-15 in addition to IL-2 induced extensive proliferation among naïve and memory CD8 T cells (16). These studies served to illustrate the pivotal role γc cytokines play in homeostasis of naïve and memory CD8 T cells.
The relationship between IL-15 signaling and CD8 T cell maintenance was further explored using animal models lacking IL-15 or IL-15Rα. In the absence of IL-15 or IL-15Ra, there is a marked reduction in T cells expressing high levels of CD44, a surrogate marker commonly used to identify activated T cells (7, 9). Furthermore, blocking IL-2/IL-15Rβ signaling in vivo in WT mice inhibited memory CD8 T-cell homeostatic proliferation (8). Because these studies were performed largely using polyclonal memory T cells in unimmunized mice, several subsequent investigations were performed with antigen-specific memory T cells. Using the vesicular stomatitis virus (VSV) and lymphocytic choriomeningitis virus (LCMV) mouse infection models, these studies demonstrated that the effect of IL-15 on memory CD8 T cells indeed served to preserve a bona fide long-lived memory CD8 T cell (6, 11). During VSV infection, IL-15Rα- and IL-15-deficient mice generated virus-specific memory CD8 T cells, but those cells incorporated BrdU poorly and the quantity of antigen-specific T cells declined over time (11). Similarly, it was reported using the LCMV model of acute viral infection that virus-specific memory CD8 T cells were unable to undergo homeostatic proliferation in the absence of IL-15 (6). From these studies, it became evident that IL-15 and its receptor play an important role in generation and/or maintenance of memory CD8 T cells.
In addition to IL-15, analyses of T cell turnover under lymphopenic conditions identified several other γc cytokines as regulators of T cell homeostasis. Specifically, IL-7 was found to be necessary for self-renewal of naïve CD8 T cells adoptively transferred into a lymphopenic environment (10, 12, 13, 17). Most notably, Goldrath et al. elegantly demonstrated that proliferation of adoptively transferred naïve polyclonal CD8 T cells is severely impaired by blocking IL-7Ra. However, blocking IL-15 signal had no effect on cell division indicating that naïve CD8 T cell proliferation is largely dependent on IL-7 (17). The requirement of IL-7 signaling for naïve T cells homeostatic proliferation was also demonstrated in studies showing that naïve CD8 T cells exhibit diminished survival/maintenance capacity after anti-IL-7 treatment in IL-15 KO mice or when naïve T cells are transferred into IL-7-deficient mice (12, 13). In contrast, irradiation of WT or IL-15-KO mice was sufficient to enable adoptively transferred memory T cells to undergo homeostatic proliferation, while basal homeostasis of memory CD8 T cells in intact mice required IL-15 signaling (17). Similar results were observed by Tan et al. in that adoptive transfer of memory CD8 T cells into irradiated IL-15-KO mice and blocking both IL-7 and IL-7Rα severely reduces the proliferative capacity of memory CD8 T cells compared to that in IL-15-KO or IL-7-KO mice (14).
While conclusions from both studies are generally consistent, it should be noted that the Tan et al. study observed that some memory T cells had undergone proliferation among the IL-15-KO-irradiated mice (14). In contrast the Goldrath et al. study reported a significant impairment in memory T cell proliferation in IL-15-KO mice (17). The discrepancy between both studies likely stems from the sorting strategy performed by each study. Goldrath et al. defined memory CD8 T cells as CD44hi CD122hi, while the Tan et al. study used a broader definition for T cell memory by isolating the total pool of CD44hi T cells, which include both CD122hi and CD122lo T cells. This discrepancy was later resolved as investigators began to assess the requirement of TCR signaling in survival of both naïve and memory T cells. Several ground-breaking studies lead to the conclusion that continuous contact with self-MHC-I/peptide complexes was critical for homeostatic proliferation and long-term survival of naïve CD8 T cells (18–20) whereas antigen-experienced memory CD8 T cells do not require MHC-I contact for their survival (18, 21–23). Among these studies were experiments performed by Boyman et al. where they generated bone marrow chimeric mice with WT and MHC-I KO T cells and measured the quantity of CD122hi versus CD122lo T cell subsets among WT and KO cells. Importantly, they reported a striking decrease in the frequency of MHC-I KO CD122lo CD8 memory T cells whereas the CD122hi population underwent only a modest decrease (24). These results resolve the discrepancy between the Tan et al. and Goldrath et al. studies while reinforcing the concept that survival of long-lived CD122hi memory T cells occurs through an antigen-independent mechanism. Collectively, these works advanced our understanding of memory T cell homeostasis and the specific role homeostatic cytokines play in this process. In the following sections, we will discuss the source of these cytokines, their known downstream signaling events, and how these signaling events may permit memory T cells to maintain or modify acquired gene expression programs during antigen-independent homeostasis.
IL-7 and IL-15 Expression and Signaling
IL-7 and IL-15 belong to the family of four alpha-helix bundle cytokines, including IL-2, IL-4, IL-9, and IL-21. The binding of IL-7 and IL-15 to their respective receptors activates several signaling pathways, including JAK/STAT and MAPK/PI3K-AKT, which results in the survival and proliferation of CD8 T cells. These cytokines are secreted by a wide spectrum of hematopoietic and non-hematopoietic cells and they bind to a multi-meric receptor complex sharing the common gamma chain receptor (γc) (25, 26) (Figure 1). For instance, IL-7 is expressed in tissues, such as bone marrow, liver, and thymus, while IL-15 is found in bone marrow stromal cells, fibroblasts, kidney, skin, astrocytes, microglia, intestine, thymus, and retina (27–31). Further, under conditions of innate microbial triggers, antigen-presenting cells such as macrophages and dendritic cells become activated and express IL-15 mRNA (31, 32). Although initially IL-15 was not detected in T cells, Neely et al. and Thurkow et al. reported the expression of IL-15 protein by normal T cells and synovial tissue T cells from patients with rheumatoid arthritis (31, 33, 34). The widespread expression of IL-7 and IL-15 further highlights the importance of these cytokines in preserving protective immunological memory among tissues where antigen reencounter may occur again in the future. This point is further illustrated by recent discoveries in the area of memory T cell tissue residency. The Masoput lab, which has been pioneers in this field, have recently reported that the tissue-resident subset of memory T cells (Trm), which protect from reinfection in non-lymphoid tissues, are dependent on IL-15 for homeostasis (35).
Figure 1. The family of common gamma chain cytokines and their receptors. The common gamma chain cytokine receptors are depicted in this cartoon showing IL-2Rγ (CD132) as the common subunit in all the receptors. Each receptor has its unique subunit that forms a heterodimer or heterotrimer receptor complex with the common gamma chain subunit. IL-4R, IL-7Rα, IL-9R, and IL-21R subunits dimerize with the common gamma chain subunit to form heterodimers that bind IL-4, IL-7, IL-9, and IL-21 cytokines, respectively. IL-2 and IL-15 receptors share two subunits, IL-2Rγ and IL-2Rβ, which trimerize with IL-2Rα or IL-15Rα to form the IL-2 or IL-15 receptor complex, respectively. The binding of each cytokine to its receptor complex results in phosphorylation of JAK1 and JAK3. The activated JAKs activate different STAT members, which then migrate to the nucleus to induce or inhibit expression of specific target genes.
In general, gamma chain cytokines exert their effect through binding to cell surface or soluble receptors, activating downstream cell signaling and consequently transcription factors which regulate a myriad of cell processes including survival and proliferation. IL-7 and IL-15, as well as other members of this cytokine family, bind to a multi-meric receptor complex sharing the common γc receptor subunit CD132. The IL-15 receptor complex shares the β-chain (IL-2/IL-15Rb, CD122) with the IL-2 receptor, but it has a unique receptor subunit, IL-15Rα. Both IL-15Rα and Rβ subunits are preferentially expressed by memory CD8 T cells compared to their naïve counterparts (11, 14, 17, 36), potentially explaining why memory CD8 T cells are more responsive to IL-15 cytokine levels compared to naïve T cells. The effects of IL-15 are mainly achieved through a trans-presentation process, but have been shown to also occur, to a lesser extent, through cis-presentation (32). In the cell contact trans-presentation scenario, IL-15 binds to the IL-15Ra chain with high affinity (Kd ~ 10−11 M) and subsequently trans-presents this membrane-bound complex to cells expressing IL-15Rb-γc (37). Once IL-15–IL-15Ra forms a trimeric complex with IL-15Rb-γc, the JAK–STAT pathway is activated, i.e., JAK1 and JAK3 are phosphorylated and subsequently recruit STAT3 and STAT5, respectively (Figures 1 and 2B). Consequently, phosphorylated STATs translocate to the nucleus, thereby promoting transcription of mitogenic and antiapoptotic genes (e.g., BCL-2, MYC, FOS, and JUN) and limit the expression of proapoptotic proteins, such as BIM and PUMA (38–40).
Complementing the IL-15 response, IL-7-receptor signaling activates a number of genes involved in survival and proliferation, such as the Bcl-2 family members, BCL-XL, c-MYC, and D-cyclins, as well as inhibits proapoptotic genes (Bad and Bax) (41, 42). Similar to IL-15, the IL-7 heterodimer has its own specific receptor, IL-7Ra (CD127), which is expressed by both naïve and memory CD8 T cells albeit the memory compartment showed higher surface expression compared to naïve counterparts (36). The investigations that lead to the identification of downstream signal targets of IL-7 and IL-15 highlight the complex nature and crucial role this signaling cascade plays in survival and proliferation of T cells. While it is now well established that maintenance of poised effector potential among memory CD8 T cells during homeostasis is important for host protection, an active area of investigation remains in determining how these acquired traits are preserved during cytokine-mediated proliferation. Notably, we have reported memory T cell subset inter-conversion, suggesting that these cytokines mediate plasticity in cell fates (43, 44). Since epigenetic mechanisms play an important role in cell fate decisions and differentiation, many groups are now examining the link between memory T cell differentiation, homeostasis, and stability/plasticity of epigenetic programs.
Epigenetic Reprogramming of T Cells During Effector and Memory Differentiation
The highly regulated process of gene expression during cellular differentiation involves a myriad of epigenetic modifications, including histone modifications and DNA methylation, that mediate changes in chromatin accessibility at gene-regulatory regions that can instill the cell with a long-lived fate (45, 46). Histone acetylation decreases the positive charge of the nucleosome, consequently reducing the affinity of histone binding to negatively charged DNA and promoting transcription (47). Additionally, an assorted combination of methylated lysines among the histones can either promote or repress transcription. For instance, trimethylation of lysine 4 (H3K4me3) is mainly associated with gene expression and is enriched in promoters of actively transcribed genes. Conversely, methylation of lysine 27 (H3K27me3) is associated with transcription inhibition (48–50). In addition to histone modifications, DNA methylation is a well-established epigenetic modification that is generally associated with transcriptional repression. Methylation of DNA results in steric hindrance of transcriptional-activators and/or recruitment of transcriptionally repressive methyl-binding proteins.
Inspired by the findings that epigenetic programs function to reinforce cell fate decisions during early development, several investigators studying memory T cell differentiation have sought to determine if epigenetic modifications serve as a mechanism for maintaining acquired effector-associated functions during memory T cell homeostasis. Using both in vivo and in vitro models, several labs have demonstrated that the Ifng promoter in naïve CD8 T cell is heavily methylated and marked by H3K27me3-repressive histone modifications. However, the activation of naïve CD8 T cells in vitro or in vivo leads to rapid DNA demethylation, removal of H3K27me3, and deposition of permissive H3K9Ac and H3K4me3 marks (51–53). Similar findings have been reported for the proximal promoter region of granzyme B (GzmB), where the GzmB promoter becomes susceptible to nuclease activity after in vitro stimulation (54). In succession with these above-described loci-specific studies, recent genome-wide approaches have been undertaken to more broadly examine the epigenetic reprogramming (DNA methylation and histone modifications) that occur during the development of a naïve T cells into effector and memory CD8 T cells. In a study performed by Araki et al. the authors performed a genome-wide assessment of H3K4me3 and H3K27me3 marks in human polyclonal naïve and memory CD8 T cells and identified different classes of transcription patterns associated with the two histone marks. First, H3K4me3 marks were associated with actively transcribed genes. Second, H3K27me3 marks were associated with repressed genes and finally a bivalent mark was associated with genes, including many effector-associated loci that are potentially poised for expression (55). To further explore the degree of epigenetic reprogramming associated with effector differentiation, Scharer et al. recently generated a global snapshot of the methylation status of naïve and effector CD8 T cell genomes following LCMV infection in mice. The authors identified approximately 650,000 differentially methylated regions between the two populations using a MeDIP-Seq approach (56). Together, the results from loci-specific and genome-wide studies provide evidence for significant plasticity of histone modifications and DNA methylation in response to TCR stimulation in CD8 T cells. Specifically, these studies document the epigenetic reprogramming of effector-associated loci. Importantly, these results also provide a potential mechanism for explaining the long-lived poised effector status of memory CD8 T cells and have prompted investigation into the acquisition and stability of these programs in self-renewing memory T cells.
The discovery that T cell effector differentiation is coupled to the acquisition of transcriptionally permissive epigenetic modifications at effector loci has further fueled the heavily debated issue centered on whether memory T cell differentiation progresses through an effector stage whether or not. We recently addressed this issue using mouse and human models of acute viral infection model. In one of our recently published studies examining the development of virus-specific mouse memory CD8 T cells, we provide evidence that memory T cells arise from a subset of effector T cells (Memory Precursor) that retain an epigenetic signature of an effector response (57). Along the same lines, Akondy et al. addressed the question of memory T cell origin by in vivo labeling rapidly dividing cells with deuterium during the effector stage of the immune response to yellow fever vaccination. YFV-vaccinated individuals consumed “heavy” water during the first 2 weeks of the immune response to the vaccine, and then deuterium incorporation among the virus-specific T cells was measured longitudinally. Strikingly, virus (YFV)-specific memory T cells remained fully labeled with deuterium more than a year post vaccination. These data demonstrate that human memory CD8 T cells are derived from a population of cells undergoing a burst in cell proliferation during the effector stage of an immune response. Moreover, the YFV-specific memory T cells retained an epigenetic fingerprint similar to the YFV-specific effector CD8 T cells (58). These studies provide further evidence that memory T cell differentiation is coupled to epigenetic modifications of effector-associated loci.
In addition to the studies focused on DNA methylation described above, Russ et al. have examined changes in histone modification during effector and memory T cell differentiation using the influenza A mouse model of acute viral infection. They observed that many of the effector-associated loci that acquired permissive histone modifications in effector CD8 T cells also acquired these histone modifications in memory CD8 T cells. Notably the promoter and gene bodies of several effector-associated molecules (i.e. IFNγ, GzmB, and GzmK) among the memory CD8 T cells acquired a transcriptionally permissive state (59). Similar to Russ et al.’s study, Crompton et al. performed a genome-wide assessment of histone modifications, but using in vitro-generated murine memory CD8 T cells subsets (Tem, Tcm, and Tscm cells). They observed that regulatory regions of effector loci (GzmB, IFNγ, and Prf) were highly enriched with permissive histone modifications in both Tem-like and Tcm-like cells (60). Taken together, these data reinforced the idea that effector-associated loci acquire transcriptionally permissive histone modifications during memory CD8 T cell differentiation.
While these mouse and human studies leave little doubt that memory T cell differentiation is associated with epigenetic reprogramming of effector-associated loci, the question of whether or not these programs are stably propagated during memory CD8 T cell homeostatic proliferation remained unanswered. To address this question, we recently defined the DNA methylation programs among human naïve and memory CD8 T cell subsets and asked whether the acquired epigenetic states of memory T cells were maintained during antigen-independent self-renewal. Naïve and memory CD8 T cell subsets (Tem, Tcm, and Tscm) were freshly isolated from healthy individuals and the methylation profile of these populations were determined at a nucleotide level of resolution by performing whole-genome bisulfite sequencing. Importantly, we observed that many effector-associated loci were methylated in naïve CD8 T cells, but were unmethylated in the long-lived Tcm and stem-cell like (Tscm) memory CD8 T cell subsets (e.g., IFNg and GzmK) (44). Having identified DNA methylation programs that were coupled to the poised effector state of long-lived human memory CD8 T cells, we next asked if these programs persisted during gamma chain cytokine-mediated proliferation. Indeed, memory CD8 T cells, including the longest lived subset Tscm, maintained their unmethylated state despite having undergone several rounds of cytokine-mediated cell division (Figure 2A). Additionally, proliferation alone was not sufficient for inducing a demethylated state among the naïve CD8 T cells. In contrast to the effector-associated loci, the lymphoid-tissue homing marker CCR7 loci underwent changes in methylation status that correlated with phenotypic changes in the cell (Figure 2A), indicating that stability of epigenetic programs among self-renewing memory CD8 T cells was a loci-specific process.
Figure 2. The effect of IL-7/15 on memory CD8 T cell epigenetic programs. (A) IL-7/15-mediated signaling and epigenetic propagation during homeostatic proliferation. IL-7 and IL-15 are expressed by hematopoietic and non-hematopoietic cells resulting in survival and proliferation of memory CD8 T cells. During memory CD8 T cell homeostatic proliferation, effector-associated programs, including IFNg, are maintained over several rounds of cell division while other programs such as CCR7 remain plastic during cell division. (B) Hypothetical model for selective modification of epigenetic programs during memory T cell self-renewal. Following IL-7 and IL-15 binding to their perspective receptors, activated JAK1 and JAK3 signaling proteins phosphorylate different members of STAT family. Activated STATs may induce or inhibit expression of key epigenetic enzymes, including DNA methyl transferases (DNMTs) and dioxygeneases, that result in de novo DNA methylation, maintenance, or demethylation of regulatory regions at target genes.
Taking advantage of a recently developed clinical protocol whereby CD45RAneg CD8 T cells from a haploidentical donor are adoptively transferred into lymphopenic bone marrow transplant patients (61), we were able to extend our observations made from in vitro studies by examining the methylation status of effector-associated methylation programs in memory T cells undergoing in vivo antigen-independent proliferation. Quite strikingly, the demethylation status of the effector programs (IFNg and Prf1) was remarkably stable, as the donor memory CD8 T cells recovered after several months of in vivo homeostasis among lymphodepleted recipients retained demethylated effector-associated loci. Collectively, these studies highlight epigenetic modifications as a mechanism for preserving acquired gene expression programs among memory CD8 T cell during antigen-independent homeostasis.
Conclusion and Future Directions
The collective studies described above broadly highlight the critical role common gamma chain cytokines play in naïve and memory CD8 T cell homeostasis. While our review focused primarily on IL-7 and IL-15, it should be noted that other family members of the gamma chain cytokines, including IL-2 and IL-21, play an important role in naïve and memory CD8 T cell homeostasis (62–64).
Because of their crucial role in preserving T cell immunity, a wide range of hematopoietic and non-hematopoietic cells expresses these cytokines. They exert their function through complex signaling pathways, including JAK/STAT and PI3K/MAPK, and regulate the expression of cell cycle, apoptotic, and antiapoptotic genes. However, how these signaling events regulate DNA methyl transferases (DNMTs) and dioxygenases (TETs) specificity—enzymes regulating addition, maintenance, and DNA demethylation—remains to be explored (Figure 2B). A recent study from our lab suggests that the methylation status of CpGs at several genes involved in memory T cell subset specification are sensitive to IL-7 and IL-15 signaling (44). While little is known regarding the specificity determinants for site-specific DNA demethylation and de novo methylation during T cell differentiation or homeostasis, recent advances in understanding the relationship between DNA methylation reprograming and transcription factor binding in other developmental systems may provide insight (65, 66). Building upon the observations that DNMT specificity can be regulated by transcription factor localization, a particular focus on assessing the relationship between de novo methylation and activation and localization of transcription factors down stream of the common gamma chain signaling cascade may be warranted. Conversely, recent studies examining the mechanisms regulating DNA demethylation have revealed cell division-dependent mechanisms that involve hydroxylation of methylated cytosines by TET enzymes. Hyrdroxylation in turn inhibits binding of DNMT1, the methyltransferase responsible for maintenance of DNA methylation, which consequently blocks propagation of DNA methylation programs to the newly synthesized daughter strand during DNA replication (67, 68). Thus, one can envision gamma chain cytokines modifying TET activity and promoting cell division-dependent demethylation during memory T cell homeostasis.
Further investigation into such cytokine-mediated changes in epigenetic programs among memory T cells will be important to guide efforts that seek to promote and maintain memory T cell subsets with desired functions. In addition to further mapping the upstream signaling events that promote changes in T cell epigenetic states, in depth investigation is needed into the role of epigenetics in T cell function during homeostasis (Figure 2B). While we have recently demonstrated that Dnmt3A-mediated de novo DNA methylation programs are causal in establishing T cell exhaustion that limit the efficacy of immune checkpoint blockade therapies (69), further understanding of the other epigenetic mechanisms involved in the development of T cell exhaustion will likely provide additional targets for therapeutic intervention. Thus, our ability to direct or skew the epigenetic state of memory T cells awaits further discoveries that will likely have major implications for current and future immunotherapeutic approaches that employ T cells in the treatment of chronic infections or cancer.
Author Contributions
All authors contributed to writing and editing the manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The reviewer TE and handling editor declared their shared affiliation.
Acknowledgments
The authors would like to thank Dr. Angela McArthur for scientific editing. The authors also thank Drs. Hazem E. Ghoneim and Ardiana Moustaki for fruitful discussions and review of our manuscript. This work was supported by the National Institutes of Health (1R01AI114442), the American Lebanese Syrian Associated Charities (ALSAC), the Immune Tolerance Network (ITN), and Assisi Foundation (to BY).
References
1. Fugmann SD, Muller S, Friedrich W, Bartram CR, Schwarz K. Mutations in the gene for the common gamma chain (gammac) in X-linked severe combined immunodeficiency. Hum Genet (1998) 103(6):730–1. doi:10.1007/PL00008710
2. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell (1993) 73(1):147–57. doi:10.1016/0092-8674(93)90167-O
3. Schmalstieg FC, Leonard WJ, Noguchi M, Berg M, Rudloff HE, Denney RM, et al. Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency. J Clin Invest (1995) 95(3):1169–73. doi:10.1172/JCI117765
4. Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature (1995) 377(6544):65–8. doi:10.1038/377065a0
5. Roifman CM, Zhang J, Chitayat D, Sharfe N. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood (2000) 96(8):2803–7.
6. Becker TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, Ma A, et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med (2002) 195(12):1541–8. doi:10.1084/jem.20020369
7. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med (2000) 191(5):771–80. doi:10.1084/jem.191.5.771
8. Ku CC, Murakami M, Sakamoto A, Kappler J, Marrack P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science (2000) 288(5466):675–8. doi:10.1126/science.288.5466.675
9. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity (1998) 9(5):669–76. doi:10.1016/S1074-7613(00)80664-0
10. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol (2000) 1(5):426–32. doi:10.1038/80868
11. Schluns KS, Williams K, Ma A, Zheng XX, Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol (2002) 168(10):4827–31. doi:10.4049/jimmunol.168.10.4827
12. Seddon B, Zamoyska R. TCR and IL-7 receptor signals can operate independently or synergize to promote lymphopenia-induced expansion of naive T cells. J Immunol (2002) 169(7):3752–9. doi:10.4049/jimmunol.169.7.3752
13. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A (2001) 98(15):8732–7. doi:10.1073/pnas.161126098
14. Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J, Surh CD. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med (2002) 195(12):1523–32. doi:10.1084/jem.20020066
15. Berard M, Brandt K, Bulfone-Paus S, Tough DF. IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J Immunol (2003) 170(10):5018–26. doi:10.4049/jimmunol.170.10.5018
16. Cho JH, Boyman O, Kim HO, Hahm B, Rubinstein MP, Ramsey C, et al. An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2. J Exp Med (2007) 204(8):1787–801. doi:10.1084/jem.20070740
17. Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C, et al. Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med (2002) 195(12):1515–22. doi:10.1084/jem.20020033
18. Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, Ahmed R. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science (1999) 286(5443):1377–81. doi:10.1126/science.286.5443.1377
19. Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science (1997) 276(5321):2057–62. doi:10.1126/science.276.5321.2057
20. Ernst B, Lee DS, Chang JM, Sprent J, Surh CD. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity (1999) 11(2):173–81. doi:10.1016/S1074-7613(00)80092-8
21. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. Cytotoxic T-cell memory without antigen. Nature (1994) 369(6482):648–52. doi:10.1038/369648a0
22. Polic B, Kunkel D, Scheffold A, Rajewsky K. How alpha beta T cells deal with induced TCR alpha ablation. Proc Natl Acad Sci U S A (2001) 98(15):8744–9. doi:10.1073/pnas.141218898
23. Lefrancois L, Marzo AL. The descent of memory T-cell subsets. Nat Rev Immunol (2006) 6(8):618–23. doi:10.1038/nri1866
24. Boyman O, Cho JH, Tan JT, Surh CD, Sprent J. A major histocompatibility complex class I-dependent subset of memory phenotype CD8+ cells. J Exp Med (2006) 203(7):1817–25. doi:10.1084/jem.20052495
25. Rochman Y, Spolski R, Leonard WJ. New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol (2009) 9(7):480–90. doi:10.1038/nri2580
26. Gao J, Zhao L, Wan YY, Zhu B. Mechanism of action of IL-7 and its potential applications and limitations in cancer immunotherapy. Int J Mol Sci (2015) 16(5):10267–80. doi:10.3390/ijms160510267
27. Link A, Vogt TK, Favre S, Britschgi MR, Acha-Orbea H, Hinz B, et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol (2007) 8(11):1255–65. doi:10.1038/ni1513
28. Mazzucchelli RI, Warming S, Lawrence SM, Ishii M, Abshari M, Washington AV, et al. Visualization and identification of IL-7 producing cells in reporter mice. PLoS One (2009) 4(11):e7637. doi:10.1371/journal.pone.0007637
29. Onder L, Narang P, Scandella E, Chai Q, Iolyeva M, Hoorweg K, et al. IL-7-producing stromal cells are critical for lymph node remodeling. Blood (2012) 120(24):4675–83. doi:10.1182/blood-2012-03-416859
30. Sawa Y, Arima Y, Ogura H, Kitabayashi C, Jiang JJ, Fukushima T, et al. Hepatic interleukin-7 expression regulates T cell responses. Immunity (2009) 30(3):447–57. doi:10.1016/j.immuni.2009.01.007
31. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood (2001) 97(1):14–32. doi:10.1182/blood.V97.1.14
32. Ma A, Koka R, Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol (2006) 24:657–79. doi:10.1146/annurev.immunol.24.021605.090727
33. Neely GG, Robbins SM, Amankwah EK, Epelman S, Wong H, Spurrell JC, et al. Lipopolysaccharide-stimulated or granulocyte-macrophage colony-stimulating factor-stimulated monocytes rapidly express biologically active IL-15 on their cell surface independent of new protein synthesis. J Immunol (2001) 167(9):5011–7. doi:10.4049/jimmunol.167.9.5011
34. Thurkow EW, van der Heijden IM, Breedveld FC, Smeets TJ, Daha MR, Kluin PM, et al. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J Pathol (1997) 181(4):444–50. doi:10.1002/(SICI)1096-9896(199704)181:4<444::AID-PATH778>3.0.CO;2-O
35. Schenkel JM, Fraser KA, Casey KA, Beura LK, Pauken KE, Vezys V, et al. IL-15-independent maintenance of tissue-resident and boosted effector memory CD8 T cells. J Immunol (2016) 196(9):3920–6. doi:10.4049/jimmunol.1502337
36. Goldrath AW, Bogatzki LY, Bevan MJ. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med (2000) 192(4):557–64. doi:10.1084/jem.192.4.557
37. Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity (2002) 17(5):537–47. doi:10.1016/S1074-7613(02)00429-6
38. Shenoy AR, Kirschnek S, Hacker G. IL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK/STAT and PI3K/AKT pathways in T cells. Eur J Immunol (2014) 44(8):2500–7. doi:10.1002/eji.201344238
39. Waldmann TA. The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy. Cancer Immunol Res (2015) 3(3):219–27. doi:10.1158/2326-6066.CIR-15-0009
40. Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, et al. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci U S A (1995) 92(19):8705–9.
41. Kim K, Lee CK, Sayers TJ, Muegge K, Durum SK. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J Immunol (1998) 160(12):5735–41.
42. Li WQ, Jiang Q, Khaled AR, Keller JR, Durum SK. Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. J Biol Chem (2004) 279(28):29160–6. doi:10.1074/jbc.M401656200
43. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, Antia R, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol (2003) 4(3):225–34. doi:10.1038/ni889
44. Abdelsamed HA, Moustaki A, Fan Y, Dogra P, Ghoneim HE, Zebley CC, et al. Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis. J Exp Med (2017) 214(6):1593–606. doi:10.1084/jem.20161760
45. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet (2012) 13(7):484–92. doi:10.1038/nrg3230
46. Russ BE, Prier JE, Rao S, Turner SJ. T cell immunity as a tool for studying epigenetic regulation of cellular differentiation. Front Genet (2013) 4:218. doi:10.3389/fgene.2013.00218
47. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res (2011) 21(3):381–95. doi:10.1038/cr.2011.22
48. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. High-resolution profiling of histone methylations in the human genome. Cell (2007) 129(4):823–37. doi:10.1016/j.cell.2007.05.009
49. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature (2011) 473(7345):43–9. doi:10.1038/nature09906
50. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet (2008) 40(7):897–903. doi:10.1038/ng.154
51. Denton AE, Russ BE, Doherty PC, Rao S, Turner SJ. Differentiation-dependent functional and epigenetic landscapes for cytokine genes in virus-specific CD8+ T cells. Proc Natl Acad Sci U S A (2011) 108(37):15306–11. doi:10.1073/pnas.1112520108
52. Fitzpatrick DR, Shirley KM, McDonald LE, Bielefeldt-Ohmann H, Kay GF, Kelso A. Distinct methylation of the interferon gamma (IFN-gamma) and interleukin 3 (IL-3) genes in newly activated primary CD8+ T lymphocytes: regional IFN-gamma promoter demethylation and mRNA expression are heritable in CD44(high)CD8+ T cells. J Exp Med (1998) 188(1):103–17. doi:10.1084/jem.188.1.103
53. Kersh EN, Fitzpatrick DR, Murali-Krishna K, Shires J, Speck SH, Boss JM, et al. Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells. J Immunol (2006) 176(7):4083–93. doi:10.4049/jimmunol.176.7.4083
54. Juelich T, Sutcliffe EL, Denton A, He Y, Doherty PC, Parish CR, et al. Interplay between chromatin remodeling and epigenetic changes during lineage-specific commitment to granzyme B expression. J Immunol (2009) 183(11):7063–72. doi:10.4049/jimmunol.0901522
55. Araki Y, Wang Z, Zang C, Wood WH III, Schones D, Cui K, et al. Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity (2009) 30(6):912–25. doi:10.1016/j.immuni.2009.05.006
56. Scharer CD, Barwick BG, Youngblood BA, Ahmed R, Boss JM. Global DNA methylation remodeling accompanies CD8 T cell effector function. J Immunol (2013) 191(6):3419–29. doi:10.4049/jimmunol.1301395
57. Youngblood B, Hale JS, Kissick HT, Ahn E, Xu X, Wieland A, et al. Effector CD8 T cells dedifferentiate into long-lived memory cells. Nature (2017) 552(7685):404–9. doi:10.1038/nature25144
58. Akondy RS, Fitch M, Edupuganti S, Yang S, Kissick HT, Li KW, et al. Origin and differentiation of human memory CD8 T cells after vaccination. Nature (2017) 552:362–367. doi:10.1038/nature24633
59. Russ BE, Olshanksy M, Smallwood HS, Li J, Denton AE, Prier JE, et al. Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation. Immunity (2014) 41(5):853–65. doi:10.1016/j.immuni.2014.11.001
60. Crompton JG, Narayanan M, Cuddapah S, Roychoudhuri R, Ji Y, Yang W, et al. Lineage relationship of CD8 T cell subsets is revealed by progressive changes in the epigenetic landscape. Cell Mol Immunol (2016) 13(4):502–13. doi:10.1038/cmi.2015.032
61. Triplett BM, Shook DR, Eldridge P, Li Y, Kang G, Dallas M, et al. Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies. Bone Marrow Transplant (2015) 50(7):1012. doi:10.1038/bmt.2015.139
62. Allard EL, Hardy MP, Leignadier J, Marquis M, Rooney J, Lehoux D, et al. Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation. Eur J Immunol (2007) 37(11):3069–77. doi:10.1002/eji.200637017
63. Mitchell DM, Ravkov EV, Williams MA. Distinct roles for IL-2 and IL-15 in the differentiation and survival of CD8+ effector and memory T cells. J Immunol (2010) 184(12):6719–30. doi:10.4049/jimmunol.0904089
64. Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol (2012) 12(3):180–90. doi:10.1038/nri3156
65. Zhu H, Wang G, Qian J. Transcription factors as readers and effectors of DNA methylation. Nat Rev Genet (2016) 17(9):551–65. doi:10.1038/nrg.2016.83
66. Yin Y, Morgunova E, Jolma A, Kaasinen E, Sahu B, Khund-Sayeed S, et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science (2017) 356(6337):eaaj2239. doi:10.1126/science.aaj2239
67. Pastor WA, Aravind L, Rao A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat Rev Mol Cell Biol (2013) 14(6):341–56. doi:10.1038/nrm3589
68. Tsagaratou A, Lio CJ, Yue X, Rao ATET. Methylcytosine oxidases in T cell and B cell development and function. Front Immunol (2017) 8:220. doi:10.3389/fimmu.2017.00220
Keywords: epigenetic regulation, CD8 T cells, homeostasis, immunological memory, cytokines
Citation: Abdelsamed HA, Zebley CC and Youngblood B (2018) Epigenetic Maintenance of Acquired Gene Expression Programs during Memory CD8 T Cell Homeostasis. Front. Immunol. 9:6. doi: 10.3389/fimmu.2018.00006
Received: 08 November 2017; Accepted: 03 January 2018;
Published: 18 January 2018
Edited by:
Ali Ellebedy, Washington University in St. Louis, United StatesReviewed by:
Nicole L. La Gruta, Monash University, AustraliaTakeshi Egawa, Washington University in St. Louis, United States
Copyright: © 2018 Abdelsamed, Zebley and Youngblood. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ben Youngblood, YmVuamFtaW4ueW91bmdibG9vZCYjeDAwMDQwO3N0anVkZS5vcmc=